Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Latest filing published 23 Sept 2026 for OnKure Therapeutics, Inc., €782.
Filing timeline
BuySaleJason A. Leverone
Insider track record
Disclosed buys
0
Disclosed sells
7
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jason A. Leverone: trading record in brief
This profile gathers the share dealings of Jason A. Leverone across 2 companies, led by OnKure Therapeutics, Inc. and Viridian Therapeutics, Inc.\DE. The record holds 11 filings, for trades running from 7 August 2018 to 21 September 2026.
No open-market purchase appears, only 7 sales worth €12k. Other entries cover 1 share grant and 3 option exercises. 2026 to date brings no purchases and 2 sales.
On 23 September 2026 came the latest disclosure, an open-market sale for €782 in OnKure Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jason A. Leverone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
302 shares@ US$2.9742Class A Common StockSEC:0001692747-26-000005:0
301 shares@ US$4.156519.5% of flowClass A Common StockSEC:0001692747-26-000001:0
302 shares@ US$2.967710.9% of flowClass A Common StockSEC:0001692747-25-000004:0
303 shares@ US$2.623510.8% of flowClass A Common StockSEC:0001692747-25-000003:0
303 shares@ US$2.384213.9% of flowClass A Common StockSEC:0001415889-25-018234:0
1,278 shares@ US$3.3276100.0% of flowClass A Common StockSEC:0001415889-25-010418:0
16,331 sharesClass A Common StockSEC:0001415889-24-024918:0
7 of 7 declarations
